Olinciguat Uses, Dosage, Side Effects and more
Olinciguat is under investigation in clinical trial NCT03892499 (A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers).
| Trade Name | Olinciguat |
| Generic | Olinciguat |
| Olinciguat Other Names | Olinciguat |
| Type | |
| Formula | C21H16F5N7O3 |
| Weight | Average: 509.397 Monoisotopic: 509.123478218 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
